ALB Insider Filing: Krupa Ander Receives 7,430 RSUs, Vesting 08/06/2028

Rhea-AI Filing Summary

Krupa Ander C., identified as an officer (General Counsel & Secretary), reported an insider acquisition in Albemarle Corp (ALB) on 08/06/2025. The Form 4 shows an award of 7,430 restricted stock units (RSUs) granted at a $0 price and reported under transaction code A (acquisition).

The RSUs are described to vest 100% on August 6, 2028 per the award agreement. Following the reported grant the filing shows 11,771 shares beneficially owned by the reporting person. The form is signed by an attorney-in-fact on 08/08/2025.

Insights

Securities Analyst

TL;DR: Routine executive compensation grant of 7,430 RSUs to Albemarle's General Counsel, vesting in three years; not immediately market-moving.

The filing documents a non‑cash award: 7,430 RSUs granted on 08/06/2025 at a reported price of $0, increasing beneficial ownership to 11,771 shares. Such awards are typical for aligning management incentives and are ordinarily part of annual or hire-related compensation programs. The grant vests fully on 08/06/2028, so there is no immediate share issuance or sale pressure. On its face this disclosure appears procedural and unlikely to have material near-term impact on Albemarle's valuation.

Corporate Governance Expert

TL;DR: Compensation disclosure appears standard; vesting schedule and documentation are specified, supporting alignment with long-term performance.

The Form 4 identifies the recipient as an officer (General Counsel & Secretary) and specifies RSUs that vest 100% on August 6, 2028. The award's full vesting date and the $0 grant price are explicitly disclosed, meeting transparency norms under Section 16. From a governance perspective, the timetable ties pay to tenure or performance over three years. The filing was executed by an attorney-in-fact, which is common for administrative filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krupa Ander C.

(Last) (First) (Middle)

4250 CONGRESS STREET

SUITE 900

(Street)

CHARLOTTE NC 28209

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ALBEMARLE CORP [ ALB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel & Sec

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/06/2025		A		7,430(1)	A	$0	11,771	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units that vest 100% on August 6, 2028, subject to the terms of the award agreement.

Remarks:

	/s/ Rebekah Richards, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Albemarle (ALB) report on Form 4?

The Form 4 reports a grant of 7,430 restricted stock units (RSUs) to Krupa Ander C. on 08/06/2025, reported as an acquisition (code A).

Who is the reporting person and what is their role at ALB?

The reporting person is Krupa Ander C., listed as an officer with the title General Counsel & Secretary.

When do the RSUs vest and are there conditions disclosed?

The RSUs vest 100% on August 6, 2028, as stated in the explanation; no additional conditions are specified in this filing.

How many Albemarle shares does the reporting person beneficially own after the transaction?

The filing shows 11,771 shares beneficially owned following the reported transaction.

Was there any cash paid for the award and who signed the form?

The grant is reported at a $0 price. The Form 4 was signed by Rebekah Richards, Attorney-in-Fact on 08/08/2025.